Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy. [electronic resource]
- The hematology journal : the official journal of the European Haematology Association 2003
- 198-207 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
1466-4860
10.1038/sj.thj.6200250 doi
Actuarial Analysis Adult Aged Aged, 80 and over Antineoplastic Agents, Alkylating--administration & dosage Cause of Death Disease Progression Female Hematologic Diseases--etiology Humans Leukemia--etiology Male Middle Aged Neoplasms--etiology Pipobroman--administration & dosage Polycythemia Vera--complications Primary Myelofibrosis--etiology Risk Factors Survival Analysis Thrombosis Treatment Outcome